[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Karl1970Karl Karl
Karl posts on X about $vktx, $nvo, $lly, profitable the most. They currently have XX followers and X posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXXXX +577%
- X Month XXXXX +119%
- X Months XXXXX +677%
- X Year XXXXX +383%
Mentions: X #
- X Week X +67%
- X Month XX +100%
- X Months XX +122%
- X Year XX +142%
Followers: XX #
- X Week XX +2.50%
- X Month XX +1.20%
- X Months XX +15%
- X Year XX -XX%
CreatorRank: undefined #
Social Influence #
Social category influence stocks XX%
Social topic influence $vktx #55, $nvo #171, $lly 20%, profitable 20%, nvo XX%
Top accounts mentioned or mentioned by @doctor_salomon @bioinvestor24 @doctorsalomon @andybradley93
Top assets mentioned Viking Therapeutics, Inc (VKTX) Novo-Nordisk (NVO) Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"@Doctor_Salomon @bioinvestor24 $lly $vktx $nvo 1/4 I doubt that buying $VKTX for $XX billion plus an additional $XX billion for production (totaling $XX billion) is profitable for $NVO"
X Link @Karl1970Karl 2025-10-16T20:51Z XX followers, XXX engagements
"2/4 especially since I estimate $NVO has earned about $XX billion in profit since the introduction of Ozempic/Wegovy. I dont think $VKTX is $XX billion better than CagriSema Amycretin UBT251 or NN419 as $VKTX lacks manufacturing capacity and detailed studies"
X Link @Karl1970Karl 2025-10-16T20:52Z XX followers, XXX engagements